Spots Global Cancer Trial Database for magnetic resonance spectroscopic imaging
Every month we try and update this database with for magnetic resonance spectroscopic imaging cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer | NCT01653093 | Prostate Cancer | 3-Tesla magneti... diffusion-weigh... dynamic contras... magnetic resona... | - | University of Cincinnati | |
| 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | NCT00429338 | Prostate Cancer | AIR-MRSI PFC-MRSI | 18 Years - | M.D. Anderson Cancer Center | |
| Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma | NCT00005084 | Brain and Centr... | conventional su... magnetic resona... radiation thera... | - 12 Years | National Cancer Institute (NCI) | |
| Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma | NCT01342757 | Adult Glioblast... Depression Recurrent Adult... | vorinostat temozolomide magnetic resona... survey administ... | 18 Years - | National Cancer Institute (NCI) | |
| Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | NCT00032058 | Prostate Cancer | magnetic resona... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors | NCT00005083 | Brain and Centr... | conventional su... magnetic resona... magnetic resona... | 18 Years - 55 Years | Jonsson Comprehensive Cancer Center | |
| Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer | NCT01938651 | Breast Cancer | high field stre... magnetic resona... chemical exchan... diffusion-weigh... dynamic contras... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | NCT06090630 | Benign Breast N... Breast Carcinom... Malignant Breas... | Diffusion Weigh... Magnetic Resona... | 18 Years - 80 Years | Jonsson Comprehensive Cancer Center | |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer | NCT03581500 | Prostate Adenoc... PSA Level Great... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Hyperpolarized ... Magnetic Resona... | - | M.D. Anderson Cancer Center | |
| Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | NCT00967954 | Prostate Cancer | antiandrogen th... releasing hormo... DNA analysis RNA analysis comparative gen... gene expression... laboratory biom... diffusion-weigh... magnetic resona... | - | National Cancer Institute (NCI) | |
| Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors | NCT03830151 | Primary Brain N... | Hyperpolarized ... Magnetic Resona... | 19 Years - | M.D. Anderson Cancer Center | |
| Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma | NCT01018329 | Brain Tumor | Magnetic Resona... Diffusion Tenso... Magnetic Resona... Dynamic Contrac... Diffusion-weigh... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | NCT00429338 | Prostate Cancer | AIR-MRSI PFC-MRSI | 18 Years - | M.D. Anderson Cancer Center | |
| Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | NCT00474604 | Breast Cancer | diffusion-weigh... dynamic contras... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | NCT03933670 | Prostate Adenoc... Prostate Cancer | Hyperpolarized ... Magnetic Resona... MRI Ultrasound ... | 18 Years - | University of California, San Francisco | |
| Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | NCT03933670 | Prostate Adenoc... Prostate Cancer | Hyperpolarized ... Magnetic Resona... MRI Ultrasound ... | 18 Years - | University of California, San Francisco | |
| Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors | NCT04908709 | Malignant Brain... | Magnetic Resona... Proton Therapy | - 21 Years | Emory University | |
| Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | NCT03933670 | Prostate Adenoc... Prostate Cancer | Hyperpolarized ... Magnetic Resona... MRI Ultrasound ... | 18 Years - | University of California, San Francisco | |
| 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer | NCT01653093 | Prostate Cancer | 3-Tesla magneti... diffusion-weigh... dynamic contras... magnetic resona... | - | University of Cincinnati | |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer | NCT01992861 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... | Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | University of Washington | |
| Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | NCT00032058 | Prostate Cancer | magnetic resona... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma | NCT02208362 | Recurrent Gliob... Recurrent Malig... Recurrent WHO G... Recurrent WHO G... Refractory Glio... Refractory Mali... Refractory WHO ... Refractory WHO ... | IL13Ralpha2-spe... IL13Ralpha2-spe... Laboratory Biom... Magnetic Resona... Magnetic Resona... Quality-of-Life... | 12 Years - 75 Years | City of Hope Medical Center | |
| Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | NCT00474604 | Breast Cancer | diffusion-weigh... dynamic contras... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer | NCT00978770 | Breast Cancer | systemic chemot... diffusion-weigh... dynamic contras... magnetic resona... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | NCT00032058 | Prostate Cancer | magnetic resona... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | NCT00429338 | Prostate Cancer | AIR-MRSI PFC-MRSI | 18 Years - | M.D. Anderson Cancer Center | |
| CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery | NCT00635245 | Breast Cancer | figitumumab imaging biomark... laboratory biom... pharmacological... conventional su... magnetic resona... neoadjuvant the... | 18 Years - | Pfizer | |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer | NCT01992861 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... | Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | University of Washington | |
| Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma | NCT04540107 | Recurrent World... Recurrent WHO G... WHO Grade II Gl... WHO Grade III G... | Hyperpolarized ... Magnetic Resona... Magnetic Resona... | 18 Years - | University of California, San Francisco | |
| Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | NCT00474604 | Breast Cancer | diffusion-weigh... dynamic contras... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate | NCT00464724 | Prostate Cancer | 3T Magnetic Res... | 18 Years - | M.D. Anderson Cancer Center | |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors | NCT03565367 | Malignant Centr... Metastatic Mali... | Gadolinium Hyperpolarized ... Magnetic Resona... Magnetic Resona... | 18 Years - | Stanford University | |
| Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | NCT00796874 | Prostate Cancer | active surveill... imaging biomark... biopsy dynamic contras... magnetic resona... magnetic resona... | 18 Years - | Roswell Park Cancer Institute | |
| MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy | NCT00963300 | Prostate Cancer | blood-oxygen-le... dynamic contras... magnetic resona... tissue-oxygen-l... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma | NCT02359565 | Constitutional ... Lynch Syndrome Malignant Gliom... Recurrent Brain... Recurrent Child... Recurrent Diffu... Recurrent Medul... Refractory Brai... Refractory Diff... Refractory Epen... Refractory Medu... | Biospecimen Col... Conventional Ma... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Dynamic Suscept... Magnetic Resona... Pembrolizumab | 1 Year - 30 Years | National Cancer Institute (NCI) | |
| Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma | NCT01018329 | Brain Tumor | Magnetic Resona... Diffusion Tenso... Magnetic Resona... Dynamic Contrac... Diffusion-weigh... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | NCT00474604 | Breast Cancer | diffusion-weigh... dynamic contras... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
